What is the treatment for bacterial conjunctivitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bacterial Conjunctivitis

For mild bacterial conjunctivitis, prescribe a 5-7 day course of broad-spectrum topical antibiotic applied 4 times daily, choosing the most convenient or least expensive option since no evidence shows superiority of any particular agent. 1, 2

Initial Treatment Approach

Mild Bacterial Conjunctivitis

  • Prescribe any broad-spectrum topical antibiotic for 5-7 days, 4 times daily 1, 2
  • Acceptable first-line options include:
    • Polymyxin B/trimethoprim 1
    • Polymyxin B/bacitracin 3
    • Tobramycin 1
    • Erythromycin 1
    • Azithromycin (1 drop twice daily for 2 days, then once daily for 5 days) 4
  • Reserve fluoroquinolones (moxifloxacin, ofloxacin, ciprofloxacin) for moderate-to-severe cases with copious purulent discharge, pain, and marked inflammation, or for contact lens wearers at higher risk for Pseudomonas infection 1, 5
  • Alternative when antibiotic access is limited: povidone-iodine 1.25% ophthalmic solution may be equally effective 1, 2

The rationale for this approach is that topical antibiotics accelerate clinical and microbiological remission by days 2-5, reduce transmissibility, and allow earlier return to school/work, even though mild bacterial conjunctivitis is self-limited 1, 2, 3. The American Academy of Ophthalmology explicitly states no clinical evidence suggests superiority of any particular antibiotic for mild cases 1.

Moderate-to-Severe Bacterial Conjunctivitis

  • Obtain conjunctival cultures and Gram staining before starting treatment 1, 6, 2
  • Start empiric fluoroquinolone therapy (moxifloxacin 3 times daily for 7 days) 5
  • Adjust antibiotics based on culture results 2
  • For MRSA infections, vancomycin may be required 1, 2

Special Situations Requiring Systemic Therapy

Gonococcal Conjunctivitis

  • Requires systemic antibiotic therapy, not topical treatment alone 1, 6, 2
  • Add saline lavage for comfort and faster resolution 1
  • Daily follow-up until resolution 2
  • If corneal involvement present, treat as bacterial keratitis 2
  • Hospitalization may be necessary for severe cases and is mandatory for neonates 1

Chlamydial Conjunctivitis

  • Requires systemic antibiotic therapy 1, 6, 2
  • For neonates: erythromycin base or ethylsuccinate 50 mg/kg/day divided into 4 doses for 14 days (clinical cure rate 96%, microbiological cure 97%) 1
  • No evidence supports adding topical therapy beyond systemic treatment 1
  • Follow-up evaluation is critical as treatment failure occurs in up to 19% of cases 2
  • In children, consider sexual abuse as a possible cause 1, 2

Follow-Up and Red Flags

When to Reassess

  • Instruct patients to return if no improvement after 3-4 days of treatment 1, 6, 2
  • At follow-up: perform interval history, visual acuity measurement, and slit-lamp biomicroscopy 1, 6

When to Refer to Ophthalmology

Refer immediately for: 1, 6

  • Visual loss
  • Moderate or severe pain
  • Severe purulent discharge
  • Corneal involvement
  • Conjunctival scarring
  • Lack of response to therapy
  • Recurrent episodes
  • Neonatal conjunctivitis (especially HSV, which can be life-threatening) 6

Critical Pitfalls to Avoid

  • Do not prescribe antibiotics for viral conjunctivitis - this accounts for unnecessary costs and promotes resistance 1
  • Avoid topical corticosteroids unless under close ophthalmologic supervision - they may prolong bacterial shedding and worsen infection 6
  • Do not use topical therapy alone for gonococcal or chlamydial conjunctivitis - systemic treatment is mandatory 1, 6, 2
  • Advise patients not to wear contact lenses during active infection 6, 5, 4
  • Counsel on hygiene measures: frequent handwashing and avoiding sharing personal items 6
  • Be aware of increasing bacterial resistance, particularly MRSA 1, 6, 2

References

Guideline

Treatment of Bacterial Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis: Frequency and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Infectious Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.